130 related articles for article (PubMed ID: 35771689)
41. Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.
Tiwari MK; Coghi P; Agrawal P; Yadav DK; Yang LJ; Congling Q; Sahal D; Wai Wong VK; Chaudhary S
Eur J Med Chem; 2021 Nov; 224():113685. PubMed ID: 34303874
[TBL] [Abstract][Full Text] [Related]
42. Synthesis, biological evaluation and SAR of naftopidil-based arylpiperazine derivatives.
Chen H; Wang CL; Sun T; Zhou Z; Niu JX; Tian XM; Yuan M
Bioorg Med Chem Lett; 2018 May; 28(9):1534-1539. PubMed ID: 29615343
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells.
İbiş K; Nalbat E; Çalışkan B; Kahraman DC; Cetin-Atalay R; Banoglu E
Eur J Med Chem; 2021 Oct; 221():113489. PubMed ID: 33951549
[TBL] [Abstract][Full Text] [Related]
44. Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma.
Zhai S; Zhang H; Chen R; Wu J; Ai D; Tao S; Cai Y; Zhang JQ; Wang L
Eur J Med Chem; 2021 Dec; 225():113824. PubMed ID: 34509167
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, anticancer evaluation and pharmacokinetic study of novel 10-O-phenyl ethers of dihydroartemisinin.
Luan S; Zhong H; Zhao X; Yang J; Jing Y; Liu D; Zhao L
Eur J Med Chem; 2017 Dec; 141():584-595. PubMed ID: 29102180
[TBL] [Abstract][Full Text] [Related]
46. Design, Synthesis and Anticancer Screening of Novel Benzothiazole-Piperazine-1,2,3-Triazole Hybrids.
Aouad MR; Soliman MA; Alharbi MO; Bardaweel SK; Sahu PK; Ali AA; Messali M; Rezki N; Al-Soud YA
Molecules; 2018 Oct; 23(11):. PubMed ID: 30373247
[TBL] [Abstract][Full Text] [Related]
47. Design, synthesis and biological evaluation of novel hydroxamic acids bearing artemisinin skeleton.
Ha VT; Kien VT; Binh le H; Tien VD; My NT; Nam NH; Baltas M; Hahn H; Han BW; Thao do T; Vu TK
Bioorg Chem; 2016 Jun; 66():63-71. PubMed ID: 27018835
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis and biological evaluation of rhein-piperazine-furanone hybrids as potential anticancer agents.
He Y; Zhang SS; Wei MX
RSC Med Chem; 2024 Mar; 15(3):848-855. PubMed ID: 38516604
[TBL] [Abstract][Full Text] [Related]
49. [Synthesis and bioactivities of novel dihydroartemisinin-piperazine derivatives containing sulfonamide].
Ma C; Li XQ; Xu J; Chen CX
Yao Xue Xue Bao; 2013 Sep; 48(9):1430-5. PubMed ID: 24358777
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C
Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178
[TBL] [Abstract][Full Text] [Related]
51. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and Biological Evaluation of Novel Heterocyclic Imines Linked Coumarin- Thiazole Hybrids as Anticancer Agents.
Goud NS; Ghouse MS; Vishnu J; Pranay J; Alvala R; Talla V; Qureshi IA; Alvala M
Anticancer Agents Med Chem; 2019; 19(4):557-566. PubMed ID: 30734685
[TBL] [Abstract][Full Text] [Related]
53. Anti-tumor activity of new artemisinin-chalcone hybrids.
Xie L; Zhai X; Liu C; Li P; Li Y; Guo G; Gong P
Arch Pharm (Weinheim); 2011 Oct; 344(10):639-47. PubMed ID: 21984014
[TBL] [Abstract][Full Text] [Related]
54. Design, synthesis and biological evaluation of novel sesquiterpene mustards as potential anticancer agents.
Xu YZ; Gu XY; Peng SJ; Fang JG; Zhang YM; Huang DJ; Chen JJ; Gao K
Eur J Med Chem; 2015 Apr; 94():284-97. PubMed ID: 25771034
[TBL] [Abstract][Full Text] [Related]
55. Hybrids of 4-hydroxy derivatives of goniothalamin and piplartine bearing a diester or a 1,2,3-triazole linker as antiproliferative agents.
Grigolo TA; Braga CB; Ornelas C; Russowsky D; Ferreira-Silva GA; Ionta M; Pilli RA
Bioorg Chem; 2021 Nov; 116():105292. PubMed ID: 34509797
[TBL] [Abstract][Full Text] [Related]
56. Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents.
Mantipally M; Gangireddy MR; Gundla R; Badavath VN; Mandha SR; Maddipati VC
Bioorg Med Chem Lett; 2019 Aug; 29(16):2248-2253. PubMed ID: 31239178
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and biological evaluation of 4-amino-5-cinnamoylthiazoles as chalcone-like anticancer agents.
Ayati A; Esmaeili R; Moghimi S; Oghabi Bakhshaiesh T; Eslami-S Z; Majidzadeh-A K; Safavi M; Emami S; Foroumadi A
Eur J Med Chem; 2018 Feb; 145():404-412. PubMed ID: 29335206
[TBL] [Abstract][Full Text] [Related]
58. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
59. Novel nitrogen mustard-artemisinin hybrids with potent anti-leukemia action through DNA damage and activation of GPx.
Dai T; Lin L; Chen H; Lu W; Yang X; Yang L; Liu Y; Cui J; Sun D
Eur J Med Chem; 2022 Dec; 244():114783. PubMed ID: 36240546
[TBL] [Abstract][Full Text] [Related]
60. Design, synthesis, and biological evaluation of indolequinone phosphoramidate prodrugs targeted to DT-diaphorase.
Hernick M; Flader C; Borch RF
J Med Chem; 2002 Aug; 45(16):3540-8. PubMed ID: 12139465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
